Fenofibrate Capsule
Product Images NDC 60505-3121

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Fenofibrate (NDC 60505-3121). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Apotex Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lbl130mg30s (Lbl130mg30s)

Fenofibrate Capsules, USP is a medication that comes in a container of 30 capsules, with each capsule containing 130 mg of micronized Fenofibrate, USP. The medication should be stored at controlled room temperature (20°C to 25°C) in a tight container. The manufacturing company is Apotex Inc., located in Toronto, Ontario, Canada, and it is marketed by Apotex Corp., based in Weston, Florida.*

FDA Label Image

Lbl43mg30s (Lbl43mg30s)

This is a description of Fenofibrate capsules, USP which contains 43 mg of micronized Fenofibrate per capsule. The recommended storage temperature is between 20°C to 25°C (68°F to 77°F) with permitted excursions between 10°C to 30°C (59°F to 86°F) as per USP Controlled Room Temperature. It is advised to dispense the capsules in a tight container. The usual dosage information can be found in the package insert. The product is manufactured by Apotex Corp and is available in a pack of 30 capsules with NDC code 60505-3120-3.*

FDA Label Image

Chemical-structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.